Opexa Therapeutics (Nasdaq: OPXA) 356% HIGHER; after announcing it entered into exclusive agreement with Novartis (NYSE: NVS) to further develop ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE